Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

MYLAN PHARMS INC

  • FDA Approval
  • May 20, 2025, 08:42 UTC
  • 59
  • 0 comments

FDA approve METHYLNALTREXONE BROMIDE

Comment Full text

NASPRESS

  • FDA Approval
  • May 20, 2025, 08:42 UTC
  • 58
  • 0 comments

FDA approve MOMETASONE FUROATE

Comment Full text

FOUGERA PHARMS

  • FDA Approval
  • May 20, 2025, 08:42 UTC
  • 66
  • 0 comments

FDA approve IMIQUIMOD

Comment Full text

MYLAN

  • FDA Approval
  • May 20, 2025, 08:42 UTC
  • 62
  • 0 comments

FDA approve ABIRATERONE ACETATE

Comment Full text

MANKIND PHARMA

  • FDA Approval
  • May 20, 2025, 08:42 UTC
  • 58
  • 0 comments

FDA approve ROSUVASTATIN CALCIUM

Comment Full text

CHANGZHOU PHARM

  • FDA Approval
  • May 20, 2025, 08:42 UTC
  • 63
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

ASCENT PHARMS INC

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 69
  • 0 comments

FDA approve RIVAROXABAN

Comment Full text

GENENTECH

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 48
  • 0 comments

FDA approve ADO-TRASTUZUMAB EMTANSINE

Comment Full text

NAVINTA LLC

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 53
  • 0 comments

FDA approve MARAVIROC

Comment Full text

HOSPIRA

  • FDA Approval
  • May 16, 2025, 08:48 UTC
  • 47
  • 0 comments

FDA approve EPINEPHRINE

Comment Full text
  • Previous
  • 184
  • 185
  • 186
  • 187
  • 188
  • Next

Search

News categories

  • Technical Exchange News(13517)
  • Event(6229)
  • SEC News(351094)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(192812)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin